We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Journal of Comparative Effectiveness Research
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

MTHFR rs1801133 polymorphism and susceptibility to colorectal cancer in Iranian population: evidence of a case–control study and meta-analysis

    Monir Sadat Haerian

    Bone and Joint Reconstruction Research Center, Shafa Yahyaeian Orthopedics Hospital, Iran University of Medical Sciences, Tehran, Iran

    ,
    Batoul Sadat Haerian

    *Author for correspondence:

    E-mail Address: batoolsadat@yahoo.com

    Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    ,
    Saadat Molanaei

    Department of Pathology, Milad Hospital, Tehran, Iran

    ,
    Farid Kosari

    Department of Pathology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran

    ,
    Shahram Sabeti

    Department of Pathology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    ,
    Farahnaz Bidari-Zerehpoosh

    Department of Pathology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    ,
    Ebrahim Abdolali

    Department of Pathology, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

    &
    Mohammad Reza Zali

    Gastroenterology & Liver Diseases Research Center (GLDRC), Shahid Beheshti University of Medical Science, Tehran, Iran

    Published Online:https://doi.org/10.2217/pgs-2016-0048

    Several studies have investigated whether MTHFR rs1801133 polymorphism contributes to risk of colorectal cancer (CRC), however the results are inconclusive. Aim: The purpose of this study was to investigate this hypothesis in a case–control study and meta-analysis in Iranian population. Materials & methods: This polymorphism was genotyped in the 2421 subjects (46% CRC patients) from Tehran. Meta-analysis was performed for determining the risk effect size of this polymorphism on CRC. Results: Both case–control study and meta-analysis showed no association between rs1801133 and CRC risk or its features. Conclusion: This study failed to identify an association between the rs1801133 and susceptibility to CRC in Iranian population.

    Papers of special note have been highlighted as: • of interest; •• of considerable interest

    References

    • 1 Fenech M. Folate (vitamin B9) and vitamin B12 and their function in the maintenance of nuclear and mitochondrial genome integrity. Mutat. Res. 733(1–2), 21–33 (2012).Crossref, Medline, CASGoogle Scholar
    • 2 Duthie SJ. Folate and cancer: how DNA damage, repair and methylation impact on colon carcinogenesis. J. Inherit. Metab. Dis. 34(1), 101–109 (2011).Crossref, Medline, CASGoogle Scholar
    • 3 Jacques PF, Bostom AG, Williams RR et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma Hcy concentrations. Circulation 93(1), 7–9 (1996).Crossref, Medline, CASGoogle Scholar
    • 4 Obeid R. The metabolic burden of methyl donor deficiency with focus on the betaine homocysteine methyltransferase pathway. Nutrients 5(9), 3481–3495 (2013).Crossref, MedlineGoogle Scholar
    • 5 Zhang T, Xin R, Gu X et al. Maternal serum vitamin B12, folate and homocysteine and the risk of neural tube defects in the offspring in a high-risk area of China. Public Health Nutr. 12(5), 680–686 (2009).Crossref, MedlineGoogle Scholar
    • 6 Zhang D, Wen X, Wu W et al. Elevated homocysteine level and folate deficiency associated with increased overall risk of carcinogenesis: meta-analysis of 83 case–control studies involving 35,758 individuals. PLoS ONE 10(5), e0123423 (2015).MedlineGoogle Scholar
    • 7 Bull CF, Mayrhofer G, O'Callaghan NJ et al. Folate deficiency induces dysfunctional long and short telomeres; both states are associated with hypomethylation and DNA damage in human WIL2-NS cells. Cancer Prev. Res. (Phila) 7(1), 128–138 (2014).Crossref, Medline, CASGoogle Scholar
    • 8 Nazki FH, Sameer AS, Ganaie BA. Folate: metabolism, genes, polymorphisms and the associated diseases. Gene 533(1), 11–20 (2014).Crossref, Medline, CASGoogle Scholar
    • 9 Torre LA, Bray F, Siegel RL et al. Global cancer statistics, 2012. CA Cancer J. Clin. 65(2), 87–108 (2015). •• Meta-analyses of MTHFR gene polymorphism and colorectal cancer risk.Crossref, MedlineGoogle Scholar
    • 10 Houlston RS, Tomlinson IP. Polymorphisms and colorectal tumor risk. Gastroenterology 121, 282–301 (2001).Crossref, Medline, CASGoogle Scholar
    • 11 Chen K, Jiang QT, He HQ. Relationship between metabolic enzyme polymorphism and colorectal cancer. World J. Gastroenterol. 11(3), 331–335 (2005).Crossref, Medline, CASGoogle Scholar
    • 12 Huang Y, Han S, Li Y et al. Different roles of MTHFR C677T and A1298C polymorphisms in colorectal adenoma and colorectal cancer: a meta-analysis. J. Hum. Genet. 52, 73–85 (2007).Crossref, Medline, CASGoogle Scholar
    • 13 Hubner RA, Houlston RS. MTHFR C677T and colorectal cancer risk: a meta-analysis of 25 populations. Int. J. Cancer 120, 1027–1035 (2007).Crossref, Medline, CASGoogle Scholar
    • 14 Taioli E, Garza MA, Ahn YO et al. Meta- and pooled analyses of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and colorectal cancer: a HuGE-GSEC review. Am. J. Epidemiol. 170, 1207–1221 (2009).Crossref, Medline, CASGoogle Scholar
    • 15 Zacho J, Yazdanyar S, Bojesen SE et al. Hyperhomocysteinemia, methylenetetrahydrofolate reductase c.677C>T polymorphism and risk of cancer: cross-sectional and prospective studies and meta-analyses of 75,000 cases and 93,000 controls. Int. J. Cancer 128(3), 644–652 (2011).Crossref, Medline, CASGoogle Scholar
    • 16 Kennedy DA, Stern SJ, Matok I et al. Folate intake, MTHFR polymorphisms, and the risk of colorectal cancer: a systematic review and meta-analysis. J. Cancer Epidemiol. 2012, 952508 (2012).MedlineGoogle Scholar
    • 17 Sheng X, Zhang Y, Zhao E et al. MTHFR C677T polymorphism contributes to colorectal cancer susceptibility: evidence from 61 case–control studies. Mol. Biol. Rep. 39, 9669–9679 (2012).Crossref, Medline, CASGoogle Scholar
    • 18 Theodoratou E, Montazeri Z, Hawken S et al. Systematic meta-analyses and field synopsis of genetic association studies in colorectal cancer. J. Natl Cancer Inst. 104, 1433–1457 (2013).CrossrefGoogle Scholar
    • 19 Yang Z, Zhang XF, Liu HX et al. MTHFR C677T polymorphism and colorectal cancer risk in Asians, a meta-analysis of 21 studies. Asian Pac. J. Cancer Prev. 13, 1203–1208 (2012).Crossref, MedlineGoogle Scholar
    • 20 Zhong S, Yang JH, Liu K et al. Quantitative assessment of the association between MTHFR C677T polymorphism and colorectal cancer risk in East Asians. Tumour Biol. 33, 2041–2051 (2012).Crossref, Medline, CASGoogle Scholar
    • 21 Zhou D, Mei Q, Luo H et al. The polymorphisms in methylenetetrahydrofolate reductase, methionine synthase, methionine synthase reductase, and the risk of colorectal cancer. Int. J. Biol. Sci. 8(6), 819–830 (2012).Crossref, Medline, CASGoogle Scholar
    • 22 Jia Y, Li M, Xue W et al. Letter to the editor: a meta-analysis of MTHFR C677T polymorphism and colorectal cancer risk in east Asians. Int. J. Colorectal. Dis. 28(3), 429–430 (2013).Crossref, MedlineGoogle Scholar
    • 23 Teng Z, Wang L, Cai S et al. The 677C>T (rs1801133) polymorphism in the MTHFR gene contributes to colorectal cancer risk: a meta-analysis based on 71 research studies. PLoS ONE 8, e55332 (2013).Crossref, Medline, CASGoogle Scholar
    • 24 Zhao M, Li X, Xing C et al. Association of methylenetetrahydrofolate reductase C677T and A1298C polymorphisms with colorectal cancer risk: a meta-analysis. Biomed. Rep. 1(5), 781–791 (2013).Crossref, Medline, CASGoogle Scholar
    • 25 Guo XP, Wang Y, Zhao H et al. Association of MTHFR C677T polymorphisms and colorectal cancer risk in Asians: evidence of 12,255 subjects. Clin. Transl. Oncol. 16(7), 623–629 (2013).Crossref, MedlineGoogle Scholar
    • 26 Fang XY, Xu WD, Huang Q et al. 5,10-methylenetetrahydrofolate reductase polymorphisms and colon cancer risk: a meta-analysis. Asian Pac. J. Cancer Prev. 15(19), 8245–8250 (2014).Crossref, MedlineGoogle Scholar
    • 27 Haerian BS, Haerian MS. Evaluation of association studies and meta-analyses of MTHFR gene polymorphisms in colorectal cancer. Pharmacogenomics 16(4), 413–425 (2015).Link, CASGoogle Scholar
    • 28 Montazeri Z, Theodoratou E, Nyiraneza C et al. Systematic meta-analyses and field synopsis of genetic association studies in colorectal adenomas. Int. J. Epidemiol. 45(1), 186–205 (2015).Crossref, MedlineGoogle Scholar
    • 29 Rai V. Evaluation of the MTHFR C677T polymorphism as a risk factor for colorectal cancer in Asian populations. Asian Pac. J. Cancer Prev. 16(18), 8093–8100 (2015).Crossref, MedlineGoogle Scholar
    • 30 Xie SZ, Liu ZZ, Yu JH et al. Association between the MTHFR C677T polymorphism and risk of cancer: evidence from 446 case–control studies. Tumour Biol. 36(11), 8953–8972 (2015).Crossref, Medline, CASGoogle Scholar
    • 31 Shiao SP, Yu CH. Meta-prediction of MTHFR gene polymorphism mutations and associated risk for colorectal cancer. Biol. Res. Nurs. 18(4), 357–369 (2016). •• Previous original studies of MTHFR gene polymorphism in Iranian population.Crossref, Medline, CASGoogle Scholar
    • 32 Mokarram P, Naghibalhossaini F, Saberi Firoozi M et al. Methylenetetrahydrofolate reductase C677T genotype affects promoter methylation of tumor-specific genes in sporadic colorectal cancer through an interaction with folate/vitamin B12 status. World J. Gastroenterol. 14(23), 3662–3671 (2008).Crossref, Medline, CASGoogle Scholar
    • 33 Haghighi MM, Radpour R, Mahmoudi T et al. Association between MTHFR polymorphism (C677T) with nonfamilial colorectal cancer. Oncol. Res. 18(2–3), 57–63 (2009).Crossref, Medline, CASGoogle Scholar
    • 34 Naghibalhossaini F, Mokarram P, Khalili I et al. MTHFR C677T and A1298C variant genotypes and the risk of microsatellite instability among Iranian colorectal cancer patients. Cancer Genet. Cytogenet. 197(2), 142–151 (2010).Crossref, Medline, CASGoogle Scholar
    • 35 Treanor D, Quirke P. Pathology of colorectal cancer. Clin. Oncol. (R. Coll. Radiol.). 19(10), 769–776 (2007).Crossref, Medline, CASGoogle Scholar
    • 36 Swartz MK. The PRISMA statement: a guideline for systematic reviews and meta-analyses. J. Pediatr. Health Care 25, 1–2 (2011).Crossref, MedlineGoogle Scholar
    • 37 Bax L, Yu LM, Ikeda N et al. Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med. Res. Methodol. 13, 50 (2006).CrossrefGoogle Scholar
    • 38 Weitzel JN, Blazer KR, MacDonald DJ et al. Genetics, genomics, and cancer risk assessment state of the art and future directions in the era of personalized medicine. CA Cancer J. Clin. 61, 327–359 (2011).MedlineGoogle Scholar
    • 39 Sabeti PC, Schaffner SF, Fry B et al. Positive natural selection in the human lineage. Science 312(5780), 1614–1620 (2006).Crossref, Medline, CASGoogle Scholar
    • 40 Hong EP, Park JW. Sample size and statistical power calculation in genetic association studies. Genomics Inform. 10(2), 117–122 (2012).Crossref, MedlineGoogle Scholar
    • 41 Wolf EJ, Harrington KM, Clark SL et al. Sample size requirements for structural equation models: an evaluation of power, bias, and solution propriety. Educ. Psychol. Meas. 76(6), 913–934 (2013).Crossref, MedlineGoogle Scholar